Multiple Myeloma Clinical Trials
A listing of Multiple Myeloma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 570 clinical trials
An Open Label, Multicenter, Phase I/II Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to Lenalidomide
This is a phase I-II open-label, multicenter, non-randomized study aiming to evaluate the efficacy and safety of belantamab mafodotin in combination with carfilzomib (Kyprolis®) and dexamethasone (Kd). Since this is the first time that this combination is being evaluated in a clinical trial, a first dose escalation part will be …
- 0 views
- 16 Jan, 2022
- 8 locations
A Multi-center Open-label Phase 2 Study of Ixazomib, Iberdomide and Dexamethasone in Elderly Patients With Multiple Myeloma at First Relapse."
in elderly patients with multiple myeloma at first relapse . The patient population will consist of adult men and women more than 70 years, who meet eligibility criteria. Following the
- 0 views
- 22 Dec, 2021
- 6 locations
A Ph1/2 Study of EMB-06 in Participants With Recurrent or Refractory Myeloma
the RP2Ds. Pharmacokinetics (PK), immunogenicity, and the anti-multiple myeloma activity of EMB-06 will also be assessed.
- 6 views
- 21 Aug, 2021
- 3 locations
A Study of Evaluating the Safety and Efficacy of ATG-010 Bortezomib and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)
Refractory Multiple Myeloma (RRMM).
- 0 views
- 06 Oct, 2021
- 28 locations
Integrin 7 BCMA CS1 CD38 and CD138 as the Single or Compound Targets for the Fourth Genenation of CAR-T Cells
According to the high expression of tumor cell-associated antigen CD138, integrin 7, CS1, CD38 and BCMA in patients with refractory/recurrent multiple myeloma, the fourth generation of CAR-T
- 0 views
- 26 Jan, 2021
- 3 locations
Dose Exploration Study OF JWCAR129 BCMA-Targeted CART for RRMM
maturation antigen (BCMA), in adult subjects with relapsed and/or refractory multiple myeloma.
- 0 views
- 27 Jan, 2021
- 1 location
Muscle Stimulation for Physical Function During Stem Cell Transplant
Some blood, bone marrow, and lymphatic (hematologic) cancers such as Hodgkin/Non-Hodgkin lymphomas, chronic lymphocytic leukemia, and multiple myeloma, are over-represented in Veterans due to
- 0 views
- 31 May, 2021
- 1 location
Evaluation of the Safety and Efficacy of the Association of Ibrutinib and Daratumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia With p53 Dysfunction
-stage clinical trials found daratumumab to be safe and to display encouraging clinical activity as a single agent in relapsed/refractory multiple myeloma (MM) patients (Lockhorst et al 2016, Lonial et
- 2 views
- 07 Jul, 2021
- 42 locations
Myeloma XIV: Frailty-adjusted Therapy in Transplant Non-Eligible Patients With Newly Diagnosed Multiple Myeloma
Trial Title: FiTNEss (UK-MRA Myeloma XIV) - Frailty-adjusted therapy in Transplant Non-Eligible patients with newly diagnosed Multiple Myeloma Overview
- 0 views
- 23 Jun, 2021
- 109 locations
A Study of WVT078 in Patients With Multiple Myeloma (MM)
relapses and/or refractory Multiple Myeloma (MM)
- 16 views
- 13 Dec, 2021
- 14 locations